Buscar resultados de ensayos clínicos
Lymphoma, Extranodal NK-T-Cell - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2014-03-02 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2017-02-09 Intervenciones: Device: 18F-FDG PET/ CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients |
Not yet recruiting |
Nombre del estudio: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2017-02-09 Intervenciones: Device: 18F-FDG PET/CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients |
Terminated |
Nombre del estudio: P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2015-08-24 Intervenciones:
|
Recruiting |
Nombre del estudio: GLIDE Regiment Followed by ASCT for Aggressive NK/T Cell Lymphoma Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2017-05-02 Intervenciones: Drug: GLIDE The dose and schedule of GLIDE chemotherapy was as follows: gemcitabine 800 mg/m 2 days 1, 8 |
Recruiting |
Nombre del estudio: Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2015-02-04 Intervenciones:
|
Recruiting |
Nombre del estudio: MESA Treatment for NK/T Cell Lymphoma Condición: Lymphoma, Extranodal NK-T-Cell Fecha: 2013-08-16 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect,Pharmacokinetics, Pharmacodynamics and EB Virus Activation Condición:
Fecha: 2016-08-20 Intervenciones:
|
Recruiting |
Nombre del estudio: Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma Condición:
Fecha: 2013-09-13 Intervenciones: Biological: CMD-003 Autologous EBV-specific T-cells |
Active, not recruiting |
Nombre del estudio: Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas Condición:
Fecha: 2003-09-17 Intervenciones:
|